河北医药
河北醫藥
하북의약
HEBEI MEDICAL JOURNAL
2014年
17期
2565-2567
,共3页
穹窿下器%高血压%nNOS阳性神经元%免疫组织化学
穹窿下器%高血壓%nNOS暘性神經元%免疫組織化學
궁륭하기%고혈압%nNOS양성신경원%면역조직화학
subfornical organ%hypertension%nitric oxide synthase%immunohistochemistry
目的:观察高血压大鼠穹窿下器内神经元型一氧化氮合( nNOS)酶阳性神经元的表达及意义。方法雌性Wistar 大鼠予以左旋硝基精氨酸( L-NNA)15 mg· d-1· kg-1腹腔注射,成功制备高血压动物模型。随机选择对照组、用药2周组、用药4周组、用药8周组,常规经心灌注固定取脑,取材后经处理进行nNOS免疫显色观察。结果nNOS免疫阳性细胞染色随着血压的升高呈现先加深后变浅的趋势。用药组与对照组比较差异有统计学意义( P<0.05)。结论穹窿下器nNOS免疫阳性神经元的改变有可能是通过影响血压调节中枢的交感活性而间接调控高血压的发生,和高血压的变化有关。
目的:觀察高血壓大鼠穹窿下器內神經元型一氧化氮閤( nNOS)酶暘性神經元的錶達及意義。方法雌性Wistar 大鼠予以左鏇硝基精氨痠( L-NNA)15 mg· d-1· kg-1腹腔註射,成功製備高血壓動物模型。隨機選擇對照組、用藥2週組、用藥4週組、用藥8週組,常規經心灌註固定取腦,取材後經處理進行nNOS免疫顯色觀察。結果nNOS免疫暘性細胞染色隨著血壓的升高呈現先加深後變淺的趨勢。用藥組與對照組比較差異有統計學意義( P<0.05)。結論穹窿下器nNOS免疫暘性神經元的改變有可能是通過影響血壓調節中樞的交感活性而間接調控高血壓的髮生,和高血壓的變化有關。
목적:관찰고혈압대서궁륭하기내신경원형일양화담합( nNOS)매양성신경원적표체급의의。방법자성Wistar 대서여이좌선초기정안산( L-NNA)15 mg· d-1· kg-1복강주사,성공제비고혈압동물모형。수궤선택대조조、용약2주조、용약4주조、용약8주조,상규경심관주고정취뇌,취재후경처리진행nNOS면역현색관찰。결과nNOS면역양성세포염색수착혈압적승고정현선가심후변천적추세。용약조여대조조비교차이유통계학의의( P<0.05)。결론궁륭하기nNOS면역양성신경원적개변유가능시통과영향혈압조절중추적교감활성이간접조공고혈압적발생,화고혈압적변화유관。
Objective To observe the expression and significance of nitric oxide synthase positive neurons in subfornical organ ( SFO) of hypertensive rats .Methods The female Wistar rats were injected with L-nitro-arginine ( L-NNA) 15 mg· d-1 · kg-1 intraperitoneally to establish animal models with hypertension .These rats were randomly were divided into control group,2 -week medication group ,4-week medication group ,8-week medication group , the rats in each group were treated by conventional cardiac perfusion and fixation , then the rats ’ brains were taken out and the paraffin sections were stained with nNOS immunohistochemical staining .Results The immunopositive cells of nNOS within SFO were stained at first deeply,then became shallower with the increase of blood pressure .Conclusion The changes of neuronal nitric oxide synthase immunoreactive neurons in subfornical organ of hypertensive rats may be related with the changes of hypertension ,which may be caused by affecting consensus activity in blood pressure regulation center to regulate indirectly the occurrence of hypertension .